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Escherichia coli RNase H has a basic extension that is involved in binding nucleic acid substrates. This basic extension
is present in the RNase H of Moloney murine leukemia virus reverse transcriptase (MLV RT), but has been deleted from the
RNase H of HIV-1 RT. Previous work showed that removing the basic loop from MLV RT (the mutant is called DC) blocked
viral replication; however, DC MLV RT retained RNase H activity in an in situ gel assay. We prepared recombinant DC MLV
RT and compared its activity to wild-type MLV RT. The DC mutant is impaired in both polymerase and RNase H activity; the
pattern of defects suggests that the basic loop is involved in the binding of MLV RT to a heteropolymeric template-primer.
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Retroviral replication requires that the single-stranded
genome of the virus be converted into double-stranded
DNA by the viral enzyme reverse transcriptase (RT). Re-
verse transcriptase has two distinct enzymatic activities
that collaborate in this conversion; a DNA polymerase
that can copy either RNA or DNA templates and an
RNase H activity that can cleave RNA if, and only if, it is
part of an RNA z DNA hybrid. In recent years, much of the
research on retroviral RTs has focused on human immu-
nodeficiency virus type 1 (HIV-1) RT because it is the
target for a number of important anti-HIV-1 drugs. The
available drugs target the polymerase activity of HIV-1
RT; appropriately this has been the primary focus of the
research effort. However, RNase H is an essential com-
ponent of RT; mutations that specifically inactivate
RNase H block viral replication (Repaske et al., 1989;
Schatz et al., 1990; Tanese et al., 1991; Tisdale et al.,
1991). Moreover, the sequences at the ends of the full-
length unintegrated linear viral DNA used as a substrate
for the integration reaction are determined (with one
base precision) by RNase H cleavage (Coffin et al., 1997;
Hughes et al., 1998).
Although HIV-1 RT is the best understood retroviral RT,
in terms of both structure and function, considerable
work has been done on other RTs, particularly the RTs of
avian sarcoma-leukosis virus (ASLV) and Moloney mu-
rine leukemia virus (MLV). Although both enzymes are
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206related to HIV-1 RT, there are important differences in
their subunit organization. HIV-1 RT is a heterodimer. The
larger subunit (p66) contains both a polymerase and an
RNase H domain; the smaller subunit (p51) corresponds
closely in sequence to the polymerase domain of the p66
subunit (Lightfoote et al., 1986). MLV RT is a monomer in
solution, although it may dimerize on a nucleic acid
substrate (Telesnitsky and Goff, 1993). MLV RT is slightly
larger (about 74 kDa) than the larger subunit of HIV-1 RT
and contains both a polymerase and an RNase H do-
main. Similar to HIV-1 RT, ASLV RT is a heterodimer.
However, the smaller subunit (a) contains both a poly-
merase and an RNase H domain; the larger subunit (b)
ontains, in addition to a polymerase and an RNase H
omain, integrase (Hizi and Joklik, 1977; Coffin et al.,
997; Hughes et al., 1998).
In addition to the differences in the subunit organiza-
ion, there are differences in the sequences of the poly-
erase and RNase H domains. For example, the RNase
domain of MLV RT has a sequence element (the basic
oop) that is absent from HIV-1 RT. Retroviral RNase H
omains are structurally related to Escherichia coli
Nase H (reviewed in Hughes et al., 1998). In contrast to
he RNases H of retroviral RTs, E. coli RNase H is not
ssociated with another domain. However, similar to the
Nase H of MLV RT, E. coli RNase H has a basic loop.
xperiments with E. coli RNase H showed that this basic
oop is involved in binding nucleic acid and that, for E.
oli RNase H, the basic loop is essential for enzymatic
ctivity because, without it, the enzyme does not bind the
ubstrate appropriately (Kanaya et al., 1991). In the case
f HIV-1 RT, the polymerase domain helps bind the nu-
leic acid substrate and compensates for the missing
207BASIC LOOP OF MLV RTbasic loop. However, in the case of MLV RT, the relative
roles of the basic loop and the polymerase domain in
binding an RNA/DNA duplex for RNase H cleavage (and
for polymerase activity) are unclear. The isolated RNase
H domain of MLV RT is enzymatically active, although it
apparently lacks some of the cleavage specificity that it
has when it is part of intact MLV RT (Schultz and Cham-
poux, 1996). Conversely, the isolated RNase H domain of
HIV-1 RT has little if any RNase H activity, although
activity can be restored by inserting a basic loop (Stahl et
al., 1994; Keck and Marqusee, 1995). What then is the
role of the basic loop in MLV RT? In some sense, the fact
that HIV-1 RT lacks a basic loop suggests that this
element is not an essential part of a retroviral RT. How-
ever, that does not necessarily mean that the basic loop
does not (at least in the case of MLV RT) play some
important role. If the basic loop of RNase H is removed
from MLV RT (the mutation was named DC), and the
mutation is introduced into a virus, the resulting virus is
replication defective (Telesnitsky et al., 1992). When the
RNase H activity was measured using an in situ gel
assay, the DC mutant had approximately the same
amount of RNase H activity as did wild-type HIV-1 RT
(Telesnitsky and Goff, 1993). In a polymerase assay with
purified recombinant RTs, the DC mutant made shorter
DNA products than the wild-type enzyme. However, the
products produced in endogenous reverse transcription
reactions done with permeabilized virions suggested
that there might be problems with both the RNase H and
the polymerase activities of the DC mutant. We have
analyzed the behavior of purified DC mutant MLV RT in in
vitro RNase H and polymerase assays. These assays
show that the DC mutation causes significant impair-
ment of both the RNase H and the polymerase functions,
which suggests that the basic loop plays an important
role in the interaction of MLV RT with nucleic acid sub-
strates.
RESULTS
RNase H activity
An RNase H substrate consisting of an 81-base-long
RNA (derived from the genome of HIV-1) and a 20-base-
long DNA was used to measure the RNase H activity of
the DC mutant of MLV RT (Gao et al., 1999). This sub-
strate was chosen because we used it (and related
RNase H substrates) previously to compare the specific-
ity of RNase H cleavage by MLV RT and HIV-1 RT. We
also compared the RNase H cleavages made by a prep-
aration of wild-type MLV RT that we expressed and
purified and those made by a commercial preparation of
MLV RT (see Fig. 1A). This comparison was included
because, in previous experiments, the MLV RT we used
was obtained commercially (Gao et al., 1999). The two
preparations of wild-type MLV RT produced the same
pattern of RNase H cleavages; the DC mutant had amuch lower cleavage efficiency. To compare both the
relative efficiency of cleavage and the specificity of
cleavage, digestions were done with increasing amounts
of the DC MLV RT. We estimate that it takes approxi-
mately 20 times as much of the DC mutant to produce the
same amount of cleavage as was seen with the wild-type
enzyme (see Fig. 1B).
Both HIV-1 RT and MLV RT make primary cleavages in
an RNA template approximately 17–18 bases from the 39
end of a DNA primer. This pattern of cleavage is in good
agreement with what is known about the three-dimen-
sional structure of the RT/nucleic acid complex (S. Sara-
fianos and E. Arnold, personal communication; H. Huang,
G. Verdine, and S. Harrison, personal communication).
However, prolonged incubation produces secondary
cleavages closer to the 39 end of the primer. In the case
of HIV-1 RT these center around a position approximately
eight bases from the end of the primer and there is a
segment between the 217 and 28 cleavages that is not
cleaved. However, the RNase H of MLV RT behaves
somewhat differently. The primary (217) cleavages are
relatively similar; however, the secondary cleavages oc-
cur over a broader interval, and there is no uncleaved
segment between the sites of the primary and secondary
cleavages (Gao et al., 1999; see also Fig. 1). The pattern
of primary (217) cleavages made by the DC mutant
cannot be distinguished from those made by wild-type
MLV RT. The pattern of secondary cleavages may be
somewhat different (Fig. 1). For the wild-type MLV RT, the
secondary cleavages were relatively efficient, giving rise
to a series of fragments that were a few bases shorter
than the fragments produced by the 217 cleavages (see
Fig. 1). However, even when 50 times as much of the DC
mutant MLV RT was added to a reaction, the secondary
cleavages were inefficient. Although the positions where
cleavages occurred were similar, the positions where
the secondary cleavages were most efficient appeared
to be different for wild-type MLV RT and the DC mutant
(Fig. 1B). Taken together, these data show that the DC
mutant has defects in RNase H activity. One possibility
was that the DC mutant bound a nucleic acid substrate
with a lower affinity. We tested this hypothesis using
polymerase assays.
Polymerase assays
We first tested both the wild-type MLV RT and the DC
mutant in a simple incorporation assay using poly(rC) z
oligo(dG) as the nucleic acid substrate. With this sub-
strate, the DC mutant had an activity similar to the wild-
type enzyme (data not shown). The kinetic behavior of
both the wild-type MLV RT and the DC mutant were
compared using poly(rC) z oligo(dG) as the nucleic
acid substrate. Analyses in which either the
poly(rC) z oligo(dG) (Fig. 2) or the dGTP (Fig. 3) were the
variable substrate showed that the K m and V max for wild-
e H ac
h was
208 BOYER ET AL.type and the DC mutant were similar (Table 1). The
relatively modest differences agree with the results of
the simple incorporation assay using poly(rC) z oligo(dG).
Because simple incorporation assays using homopoly-
meric templates do not always reveal subtle defects in
reverse transcription, we also did extension assays us-
ing a heteropolymeric template. In this type of assay, a
radioactively labeled primer is annealed to a long DNA
template and extended by RT. The assay was done both
with and without a nucleic acid trap. The trap is added
after RT is given an opportunity to bind to the template-
primer (see Materials and Methods). The trap is added in
vast excess, which allows the prebound RT to extend the
labeled primer, but restricts the extension reaction to one
round of synthesis. Once RT falls off, the trap prevents it
FIG. 1. RNase H activity of wild-type and mutant MLV RT. (A) Compa
MLV RT we prepared which was present at 100 ng/ml (MLV-wt). In a
20-base-long oligonucleotide (Gao et al., 1999). The RNA preparation
in length. The RTs were incubated with the RNA/DNA duplex for periods
and the DC mutant (DC). Because the DC mutant had much less RNas
and 503 the amount of the DC mutant as the wild-type enzyme (whicfrom binding to the labeled primer for a second round of
synthesis. As expected, both wild-type MLV RT and theDC mutant make longer DNA products when multiple
rounds of synthesis are permitted. In both the assay
without the trap and the assay with the trap, the wild-type
enzyme makes much longer products than does the DC
mutant. The difference seen in the presence of the trap
(where true processivity is measured) is particularly
striking (Fig. 4).
DISCUSSION
The fact that MLV virus carrying the DC mutation
cannot replicate implies that the mutation causes some
serious defect in RT (Telesnitsky et al., 1992). It is clear
that the DC mutant has significant defects in vitro; it has,
relative to wild-type MLV RT, a greatly reduced proces-
f the RNase H activity of HIV-1 RT, MLV RT from BRL (MLV-BRL), and
s, the substrate is an 81-base-long 32P-labeled RNA hybridized to a
these experiments also contains shorter RNAs about 60 nucleotides
g from 0.25–16 min. (B) RNase H activity of wild-type MLV RT (MLV-wt)
tivity than the wild-type enzyme, experiments were done with 13, 53,
present in the reaction at 50 ng/ml).rison o
ll case
used in
ranginsivity, and the RNase H activity is also substantially
reduced. In an endogenous reaction the DNA made by
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209BASIC LOOP OF MLV RTmutant virions is significantly shorter than that made by
wild-type virions and there is only a limited amount of
transfer in the first-strand transfer reaction (Telesnitsky
et al., 1992).
Using only these data, the simple conclusion would be
that the DC mutant has a lower affinity for the nucleic
acid substrate, an idea that is supported by gel shift
analyses (Telesnitsky and Goff, 1993). However, the ki-
netic analyses suggest that a somewhat more compli-
cated interpretation is needed. The kinetic analyses
showed that, for a poly(rC) z oligo(dG) substrate, the DC
mutant was only modestly impaired relative to wild-type
MLV RT, using either the nucleic acid or dGTP as the
variable substrate. Much of this is easy to explain. There
is no reason to expect that V max for polymerase would be
ubstantially affected; the polymerase active site is un-
ffected by the DC mutation. Nor would one expect that
he K m for dGTP would be affected, unless the DC mu-
tation affected the positioning of the nucleic acid at the
active site. The fact that the K m for dGTP is not greatly
ffected suggests that this is not the case. What is
urprising is that the K m for poly(rC) z oligo(dG) is only
modestly affected. Although K m does not directly mea-
sure nucleic acid binding, it is a related property. The
simple explanation is that the DC mutant treats ho-
FIG. 2. MLV-RT kinetics using poly(rC) z oligo(dG) as the variable
substrate (see Materials and Methods). Velocity (V) is expressed as
pmol of dGTP incorporated/10 min. The concentration of substrate [S]
is in mg/ml poly(rC) z oligo(dG). The plot of V versus V/[S] allows the
alculation of V max (the Y axis intercept) and K m (the X axis intercept is
max/K m). All reactions were done in triplicate.mopolymeric and heteropolymeric substrates differently.
This idea is supported by previous work with a differenthomopolymeric substrate, poly(rA) z oligo(dT), which also
suggested that the polymerase activity of the DC enzyme
was only modestly impaired with a homopolymeric sub-
strate (Telesnitsky and Goff, 1993). These results under-
score the importance of taking the analyses of retroviral
reverse transcriptases beyond simple homopolymers.
Although homopolymers are simple and convenient, the
results can, as we show here, be quite different when
heteropolymers are used.
The results of the RNase H assay, and the processivity
FIG. 3. MLV-RT kinetics using dGTP as the variable substrate (see
Materials and Methods). Velocity (V) is expressed as pmol of dGTP
incorporated/10 min. The concentration of substrate [S] is in mM dGTP.
he plot of V versus V/[S] allows the calculation of V max (the Y axis
ntercept) and K m (the X axis intercept is V max/K m). All reactions were
done in triplicate.
TABLE 1
MoMLV Kinetics
With rC z dG as variable substrate
Vmax (pmol dGTP/min) Km (mg/ml rC z dG)
WT MoMLV 21.5 6 0.6 4.4 6 0.4
DC 15.2 6 0.8 5.1 6 0.7
With dGTP as variable substrate
Vmax (pmol dGTP/min) Km (mM dGTP)
WT 51.9 6 0.9 92.8 6 1.1
DC 49.0 6 0.5 108.9 6 3.6
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210 BOYER ET AL.analyses, do suggest that the DC mutant binds a hetero-
olymeric template-primer less well than wild-type MLV
T. This is a reasonable expectation based on both the
vailable data on the role of the basic loop in E. coli and
the retroviral RNases H and on data derived from endog-
enous RT assays with virus carrying the DC mutation.
This means that, in MLV RT, not only is the interaction of
the nucleic acid with the polymerase domain important
for RNase H activity; the interaction of the nucleic acid
with the basic loop of RNase H is important for polymer-
FIG. 4. Polymerase activity of wild-type and DC MLV-RT in the
presence and absence of a poly(rC) z oligo(dG) trap. The presence of a
rap limited the extension of the primer to one cycle. After the polymer-
se released the labeled template-primer, it will bind to the trap. The
bsence of the trap allowed multiple rounds of primer extension to
ccur. A negative control lane (template-primer with no added RT) is at
he far right. All reactions were done in duplicate.ization on a heteropolymeric DNA/DNA substrate. This is
in apparent contrast to the results obtained for HIV-1 RT
i
sby X-ray crystallography. There is no basic loop in the
RNase H domain of HIV-1 RT; a DNA/DNA substrate has
only modest interactions with the RNase H domain. How-
ever, even in the case of HIV-1 RT, mutations in RNase H
can affect the ability of the enzyme to act as a polymer-
ase (Reardon et al., 1991; Dudding and Mizrahi, 1993;
Volkman et al., 1993). This suggests that for MLV RT and
HIV-1 RT, the two enzymatic activities, polymerase and
RNase H, while part of two separate domains, are still
interdependent, at least in part, because both domains
have a role in binding (and properly positioning) nucleic
acid substrates.
MATERIALS AND METHODS
Moloney murine leukemia virus RT
The expression clone for the MLV RT has been previ-
ously described (Hizi and Hughes, 1988). Briefly, codons
for two extra amino acids (methionine and glycine) were
added to the 59 end of the MLV-RT coding region to
generate an initiating ATG codon and an NcoI site. A
termination codon and HindIII site were added to the 39
end of the coding region. The resulting construct was
cloned into the expression vector pUC12N which causes
constitutive expression of the recombinant protein in E.
coli. The clone DC, which deletes the basic loop region
between Ile593 and Leu603, was the generous gift of
Steve Goff. The DC clone was converted to our expres-
sion system by using the SalI and BglII restriction endo-
nuclease recognition sites which flank the basic loop
region. The 735-bp SalI/BglII fragment from DC was
cloned into SalI/BglII-digested MLV-RT pUC12N, then se-
quenced to verify the construct.
To obtain the MLV-RT protein, MLV-RT pUC12N and DC
pUC12N were transformed into competent DH5a E. coli
GIBCO BRL). Individual colonies were picked and di-
uted into 1.0 liter of NZY broth supplemented with 100.0
mg/ml ampicillin. The cultures were grown at 37°C with
agitation for 16 h. The bacteria were harvested by cen-
trifugation and stored frozen at 280°C. Frozen cells (10.0
g) were homogenized in 10 ml of Buffer A (10.0 mM
Tris–Cl, pH 8.0, 1.0 mM EDTA, 25% sucrose) using a
Brinkman polytron. Added to the suspension was 2.0 ml
of 0.5 M EDTA with 5.0 mg/ml lysozyme. The mixture was
incubated at 4°C for 25 min. All subsequent steps are
done at 4°C. The cells were disrupted by the addition of
16.0 ml of Buffer B (50 mM Tris–Cl, pH 8.0, 6.25 mM
EDTA, 0.1% Triton X-100, 50 mM NaCl, 0.2 mM PMSF).
After incubation for 25 min, 32 ml of Buffer C (50 mM
Tris–Cl, pH 8.0, 6.25 mM EDTA, 0.1% Triton X-100, 950 mM
NaCl, 0.2 mM PMSF) was added to the disrupted cells
followed immediately by the addition of 1.8 ml 10% poly-
ethylene imine (pH 7.5). After 15 min, the insoluble ma-
terial was removed by centrifugation at 4300g for 30 min
n an SS-34 rotor. At this point, the supernatant can be
tored at 270°C if needed.
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211BASIC LOOP OF MLV RTThe supernatant was thawed and dialyzed against
1000 ml of Buffer D (20 mM HEPES, pH 8.0, 2.0 mM DTT,
0.2 mM EDTA, 10% glycerol) for 4 h, then dialyzed against
500 ml of Buffer D 1 20 mM NaCl for 12 h. The sample
as removed from dialysis and the conductivity was
djusted with 2 M NaCl to a value equivalent of 40 mM
aCl. The sample was centrifuged at 5000g for 30 min
and the supernatant loaded on a 1.5 3 11.0 cm Q-
sepharose column (Amersham-Pharmacia) equilibrated
with Buffer D. Flow rate was 1.0 ml/min. The flow through
from this column contains the bulk of the MLV-RT.
The flow through from the Q-sepharose column was
diluted 1:1 with Buffer E (20 mM HEPES, pH 7.0, 2.0 mM
DTT, 0.2 mM EDTA, 5.0 mM NaCl) and the pH adjusted
from pH 7.6 to pH 7.2 using HCl. The resulting conduc-
tivity was equivalent to 20 mM NaCl. The sample was
loaded on a 1.0 3 12.0 cm column containing CM-tris
acryl (Bio-Sepra) equilibrated with Buffer E and the flow
rate adjusted to 1.0 ml/min. The column was washed with
10 column volumes of Buffer E. The MLV-RT was eluted
from the column by running a 50 3 50 ml, 5.0 to 200 mM
aCl linear gradient. Fractions (2.5 ml) were collected
nd aliquots analyzed by SDS–PAGE. The fractions
hich contained the MLV-RT were pooled and dialyzed
gainst 3 3 1000 ml volumes of Buffer F (50 mM Tris–
Cl, pH 8.2). The dialysate was centrifuged at 12,000g for
0 min. The conductivity of the supernatant was mea-
ured and adjusted with water to a value equivalent to 20
M NaCl. A 1.5 3 5.5 ml Q-sepharose column was
quilibrated with Buffer F. The sample was applied to this
olumn and the flow rate adjusted to 1.0 ml/min. The
olumn was washed with 10 column volumes of Buffer F
nd the MLV-RT eluted with a 50 3 50 ml Buffer F to
Buffer G (50 mM HEPES, 25 mM MES pH 6.2) linear
gradient. Fractions were analyzed by SDS–PAGE and
fractions containing the MLV-RT were pooled. NaCl was
added to the sample to a final concentration of 180 mM
and the sample concentrated by using a 30-kDa cutoff
centrifugal concentrator (Amicon).
Polymerase assays
While it has been reported that MLV-1 RT may prefer
Mn11 to Mg11 (15), the MLV-RT in this system was more
active with Mg11 than with Mn11 (data not shown). For
ach sample to be assayed, 0.5 ml of 1.0 OD/ml 247
sequencing primer (New England Biolabs) was 59 end-
labeled with [g-32P]ATP and T4 polynucleotide kinase.
fter purification, the labeled primer was annealed to
ingle-stranded M13mp18 DNA (1.0 ml of a 0.25 mg/ml
tock for each sample to be assayed) by heating and
low cooling. The labeled template-primer was resus-
ended in 25 mM Tris–Cl (pH 8.0), 30 mM KCl, 8.0 mM
gCl2, 2.0 mM DTT, 100 mg/ml BSA, and 10.0 mMCHAPS. One microgram of wild-type RT or DC was
added to each tube and allowed to bind the labeled
w
ttemplate-primer for 2 min at room temperature. Reac-
tions were initiated by adding dNTPs to a final concen-
tration of 10.0 mM each (for the no trap assay) or by the
addition of dNTPs to a final concentration of 10.0 mM
ach and poly(rC) z oligo(dG) to a final concentration of
.5 U/ml (for the trap assay). After transferring to 37°C,
he reactions were allowed to proceed for 10 min, then
alted by phenol/chloroform extraction. The samples
ere precipitated by the addition of 1 volume isopropa-
ol, fractionated by electrophoresis on a 6.0% polyacryl-
mide gel and autoradiographed.
LV-RT kinetics
The kinetic assays are similar to that described for
IV-1 RT (2) with modifications. In brief, the kinetics were
one with either dGTP or poly(rC) z oligo(dG) as the vari-
ble substrate. With dGTP as the variable substrate, the
mount of [a-32P]dGTP incorporated into poly(rC) z
oligo(dG) at four different dGTP concentrations (ranging
from 7.5 to 60.0 mM) was measured. To do this, a trace
mount of [a-32P]dGTP was added to a stock solution of
300 mM dGTP. An aliquot from this stock solution was
counted in a liquid scintillation counter to determine the
ratio of cpm/pmol dGTP in the mixture. The stock solu-
tion was then used to make four dGTP mixtures having
final concentrations ranging from 37.5 to 300 mM. Wild-
ype or DC MLV-RT (0.2 mg) was added to 50 ml of 23
uffer (50 mM Tris–Cl (pH 8.0), 60 mM KCl, 16 mM MgCl2,
4.0 mM DTT, 20 mg/ml poly(rC) z oligo(dG), 200 mg/ml
SA, and 20.0 mM CHAPS) and the volume adjusted to
0 ml with water. The tubes were incubated at 37°C for
5 min to allow the samples to reach equilibrium. The
reactions were initiated by the addition of 20 ml of the
appropriate dGTP mixture described above. The reac-
tions were allowed to proceed for 10 min at 37°C. The
reactions were halted by the addition of 10 ml sheared,
denatured salmon sperm DNA and 3 ml of 10% TCA. The
precipitate was collected on Whatman GF/C glass filters
by suction filtration and counted. From the cpm/pmol
dGTP ratio described above, the pmol of dGTP incorpo-
rated during the 10-min incubation is calculated. All as-
says were done in triplicate.
For the poly(rC) z oligo(dG) assays, five different
poly(rC) z oligo(dG) concentrations ranging from 0.625 to
10.0 mg/ml were tested. Using a 1.0 mg/ml poly(rC) z
ligo(dG) stock solution, five solutions of poly(rC) z
ligo(dG) were made. Wild-type or DC MLV-RT (0.2 mg)
as added to 50 ml of 23 buffer (50 mM Tris–Cl (pH 8.0),
60 mM KCl, 16 mM MgCl2, 4.0 mM DTT, 100 mM dGTP
plus [a-32P]dGTP, 200 mg/ml BSA, and 20.0 mM CHAPS)
nd the volume adjusted to 80 ml with water. The tubes
ere incubated at 37°C for 5 min to allow the samples to
each equilibrium. An aliquot of the 23 sample buffer
as counted in a liquid scintillation counter to determine
he ratio of cpm/pmol dGTP in the mixture. The reactions
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212 BOYER ET AL.were initiated by the addition of 20 ml of the appropriate
poly(rC) z oligo(dG) mixture described above. The reac-
tions were allowed to proceed for 10 min at 37°C. The
reactions were halted by the addition of 10 ml sheared,
denatured salmon sperm DNA and 3 ml of 10% TCA. The
precipitate was collected on Whatman GF/C glass filters
by suction filtration and counted. From the cpm/pmol
dGTP ratio described above, the pmol of dGTP incorpo-
rated during the 10-min incubation is calculated. All as-
says were done in triplicate.
Construction of the plasmid used to synthesize RNA
in vitro
A 35-base fragment from the HIV-1 provirus clone
pNL4-3 (1), including the polypurine tract from the HIV-1
genome (positions 9049–9083), was linked to 30 ad-
enines and inserted into the EcoRI and HindIII restriction
sites of plasmid pGEM-3Zf (Promega, Madison, WI). The
sequence and structure of the resulting plasmid,
pGPA35, were verified both by restriction enzyme map-
ping and by dsDNA sequencing (Gao et al., 1998).
RNA template preparation
The RNA template used in the RNase H cleavage
assay was synthesized from linearized plasmid DNA
(pGPA35) by in vitro run-off transcription with T7 RNA
polymerase, using MEGAscripts RNA synthesis kit (Am-
bion, Inc., Austin, TX) in the presence of 160 mCi of
[a-32P]UTP. The RNA was pulse and chase labeled and
he whole transcription reaction was heat inactivated at
0°C for 20 min. The resulting RNA was purified using
he PolyA Tract mRNA Isolation System composed of
iotinylated oligo dT and streptavidin-coated magnetic
articles (Promega, Madison, WI). The amount of radio-
ctive UTP incorporation into RNA was determined by
cintillation counting (Gao et al., 1998).
NA oligonucleotide preparation
DNA oligonucleotides were synthesized and gel puri-
ied by Life Technologies (Rockville, MD). The lyophilized
ligonucleotides were dissolved in diethylpyrocarbon-
te-treated water and stored at 220°C.
Nase H cleavage assays
An amount of 600,000 cpm of the 32P-labeled RNA
emplate that was synthesized from linearized pGPA35
;100 ng) was hybridized to approximately 20 ng of the
ndividual oligonucleotide as described above in the
resence of 50 mM Tris–Cl (pH 8.0), 50 mM NaCl, 2.0 mM
TT, 100 mg/ml acetylated BSA, and 10 mM CHAPS. The
mixtures of RNA and oligonucleotides were heated to
70°C for 10 min and then slowly cooled to room temper-
ature. The reactions were initiated by adding 750 ng of
purified wild-type or mutant MLV RT and MgCl2 to a finalconcentration of 5 mM in a final volume of 60 ml and
were then incubated at 37°C. Samples were removed at
0.25, 1, 4, and 16 min and the reactions were terminated
by adding 23 RNA loading buffer. The products were
heat denatured and separated 15% polyacrylamide/7 M
urea gel in Tris-borate/EDTA buffer at 1600 V for approx-
imately 90 min (Gao et al., 1998). The gel was dried and
autoradiographed for several hours overnight.
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